The use of biomarkers has been useful in clinical practice, especially troponinI, BNP, and N-terminal-pro-BNP (NT-pro-BNP), which may be found in abnormallevels in cirrhosis.16-18 Troponin I elevation has beenassociated to a decrease in systolic output and left ventricular mass, but withno correlation to the severity of cihrrosis.19 Pro-BNP elevation has been associated tointraventricular septum wall thickness and ventricular wall thickness. Here, NPPB is linked to Cirrhosis.